Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Calcium Phosphate Nanoparticle-Based Vaccines as a Platform for Improvement of HIV-1 Env Antibody Responses by Intrastructural Help.

Damm D, Rojas-Sánchez L, Theobald H, Sokolova V, Wyatt RT, Überla K, Epple M, Temchura V.

Nanomaterials (Basel). 2019 Sep 27;9(10). pii: E1389. doi: 10.3390/nano9101389.

2.

Laboratory diagnosis of congenital CMV infection in newborns: Impact of pre-analytic factors.

Kohmer N, Nagel A, Berger A, Enders M, Hamprecht K, Korn K, Kortenbusch M, Überla K, Rabenau HF.

J Clin Virol. 2019 Jun;115:32-36. doi: 10.1016/j.jcv.2019.03.017. Epub 2019 Apr 2.

PMID:
30959324
3.

Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie.

Wagner N, Assmus F, Arendt G, Baum E, Baumann U, Bogdan C, Burchard G, Föll D, Garbe E, Hecht J, Müller-Ladner U, Niehues T, Überla K, Vygen-Bonnet S, Weinke T, Wiese-Posselt M, Wojcinski M, Zepp F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):494-515. doi: 10.1007/s00103-019-02905-1. German. No abstract available.

PMID:
30899964
4.

Background paper to the decision to recommend the vaccination with the inactivated herpes zoster subunit vaccine : Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute.

Siedler A, Koch J, Garbe E, Hengel H, von Kries R, Ledig T, Mertens T, Zepp F, Überla K.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Mar;62(3):352-376. doi: 10.1007/s00103-019-02882-5. No abstract available.

PMID:
30848293
5.

Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination.

Heß R, Storcksdieck Genannt Bonsmann M, Lapuente D, Maaske A, Kirschning C, Ruland J, Lepenies B, Hannaman D, Tenbusch M, Überla K.

Viruses. 2019 Feb 13;11(2). pii: E153. doi: 10.3390/v11020153.

6.

Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines.

Elsayed H, Nabi G, McKinstry WJ, Khoo KK, Mak J, Salazar AM, Tenbusch M, Temchura V, Überla K.

J Virol. 2018 Jun 29;92(14). pii: e00141-18. doi: 10.1128/JVI.00141-18. Print 2018 Jul 15.

7.

Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells.

Ngu LN, Nji NN, Ambada G, Ngoh AA, Njambe Priso GD, Tchadji JC, Lissom A, Magagoum SH, Sake CN, Tchouangueu TF, Chukwuma GO, Okoli AS, Sagnia B, Chukwuanukwu R, Tebit DM, Esimone CO, Waffo AB, Park CG, Überla K, Nchinda GW.

Immun Inflamm Dis. 2018 Mar;6(1):163-175. doi: 10.1002/iid3.209. Epub 2017 Dec 4.

8.

[Attenuated zoster vaccine is not recommended as a standard vaccine : Missed opportunity or logical implementation of the evidence-based approach of the Standing Committee on Vaccination].

Überla K.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Oct;60(10):1065-1066. doi: 10.1007/s00103-017-2632-8. German. No abstract available.

PMID:
28905082
9.

Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4+ and CD8+ T-Cell Responses.

Sauermann U, Radaelli A, Stolte-Leeb N, Raue K, Bissa M, Zanotto C, Krawczak M, Tenbusch M, Überla K, Keele BF, De Giuli Morghen C, Sopper S, Stahl-Hennig C.

J Virol. 2017 Nov 14;91(23). pii: e01120-17. doi: 10.1128/JVI.01120-17. Print 2017 Dec 1.

10.

Generation of T follicular helper cells in vitro: requirement for B-cell receptor cross-linking and cognate B- and T-cell interaction.

Kolenbrander A, Grewe B, Nemazee D, Überla K, Temchura V.

Immunology. 2018 Feb;153(2):214-224. doi: 10.1111/imm.12834. Epub 2017 Oct 9.

11.

A clinician's plea to test glioma patients for CMV.

Goerig NL, Frey B, Überla K, Gaipl U, Fietkau R.

Neuro Oncol. 2017 Sep 1;19(9):1282-1283. doi: 10.1093/neuonc/nox080. No abstract available.

12.

In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4+ T cell responses protecting from airway challenge with recombinant vaccinia-gag virus.

Ngu LN, Nji NN, Ambada GE, Sagnia B, Sake CN, Tchadji JC, Njambe Priso GD, Lissom A, Tchouangueu TF, Manga Tebit D, Waffo AB, Park CG, Steinman RM, Überla K, Nchinda GW.

Immun Inflamm Dis. 2019 Jun;7(2):55-67. doi: 10.1002/iid3.151. Epub 2017 Mar 13.

13.

Intrastructural help: improving the HIV-1 envelope antibody response induced by virus-like particle vaccines.

Temchura V, Überla K.

Curr Opin HIV AIDS. 2017 May;12(3):272-277. doi: 10.1097/COH.0000000000000358. Review.

PMID:
28422791
14.

Application of the PAMONO-Sensor for Quantification of Microvesicles and Determination of Nano-Particle Size Distribution.

Shpacovitch V, Sidorenko I, Lenssen JE, Temchura V, Weichert F, Müller H, Überla K, Zybin A, Schramm A, Hergenröder R.

Sensors (Basel). 2017 Jan 27;17(2). pii: E244. doi: 10.3390/s17020244.

15.

Nanoparticle-based B-cell targeting vaccines: Tailoring of humoral immune responses by functionalization with different TLR-ligands.

Zilker C, Kozlova D, Sokolova V, Yan H, Epple M, Überla K, Temchura V.

Nanomedicine. 2017 Jan;13(1):173-182. doi: 10.1016/j.nano.2016.08.028. Epub 2016 Sep 2.

PMID:
27593489
16.

Mucosal expression of DEC-205 targeted allergen alleviates an asthmatic phenotype in mice.

Maaske A, Devos FC, Niezold T, Lapuente D, Tannapfel A, Vanoirbeek JA, Überla K, Peters M, Tenbusch M.

J Control Release. 2016 Sep 10;237:14-22. doi: 10.1016/j.jconrel.2016.06.043. Epub 2016 Jul 1.

17.

Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain.

Goerig NL, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt MA, Dörfler A, Engelhorn T, Eyüpoglu I, Rühle PF, Putz F, Semrau S, Gaipl US, Fietkau R.

Neuro Oncol. 2016 Dec;18(12):1664-1672. Epub 2016 Jun 10.

18.

Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.

Goerig N, Semrau S, Frey B, Korn K, Fleckenstein B, Überla K, Dörfler A, Putz F, Gaipl US, Fietkau R.

Strahlenther Onkol. 2016 Jul;192(7):489-97. doi: 10.1007/s00066-016-0987-7. Epub 2016 May 31.

PMID:
27245820
19.

The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.

Storcksdieck genannt Bonsmann M, Niezold T, Hannaman D, Überla K, Tenbusch M.

Vaccine. 2016 Apr 4;34(15):1744-51. doi: 10.1016/j.vaccine.2016.02.059. Epub 2016 Mar 3.

PMID:
26945099
20.

Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells.

Storcksdieck genannt Bonsmann M, Niezold T, Temchura V, Pissani F, Ehrhardt K, Brown EP, Osei-Owusu NY, Hannaman D, Hengel H, Ackerman ME, Streeck H, Nabi G, Tenbusch M, Überla K.

J Immunol. 2015 Nov 15;195(10):4861-72. doi: 10.4049/jimmunol.1501377. Epub 2015 Oct 14.

21.

Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.

von Gunten A, Schlaefke S, Überla K.

World J Biol Psychiatry. 2016 Dec;17(8):622-633. Epub 2015 Jul 30. Review.

PMID:
26223956
22.

Application of surface plasmon resonance imaging technique for the detection of single spherical biological submicrometer particles.

Shpacovitch V, Temchura V, Matrosovich M, Hamacher J, Skolnik J, Libuschewski P, Siedhoff D, Weichert F, Marwedel P, Müller H, Überla K, Hergenröder R, Zybin A.

Anal Biochem. 2015 Oct 1;486:62-9. doi: 10.1016/j.ab.2015.06.022. Epub 2015 Jun 18.

PMID:
26095398
23.

Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.

Kohlmann R, Salmen A, Chan A, Knabbe C, Diekmann J, Brockmeyer N, Skaletz-Rorowski A, Michalik C, Gold R, Überla K.

Mult Scler. 2015 Dec;21(14):1823-32. doi: 10.1177/1352458515576984. Epub 2015 Mar 31.

PMID:
25828755
24.

DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?

Niezold T, Storcksdieck Genannt Bonsmann M, Maaske A, Temchura V, Heinecke V, Hannaman D, Buer J, Ehrhardt C, Hansen W, Überla K, Tenbusch M.

Immunology. 2015 Aug;145(4):519-33. doi: 10.1111/imm.12467. Epub 2015 Apr 30.

25.

Divergence of primary cognate B- and T-cell proliferative responses to subcutaneous and intravenous immunization with virus-like particles.

Temchura V, Kalinin S, Nabi G, Tippler B, Niezold T, Uberla K.

Viruses. 2014 Aug 22;6(8):3334-47. doi: 10.3390/v6083334.

26.

Cytoplasmic HIV-RNA in monocytes determines microglial activation and neuronal cell death in HIV-associated neurodegeneration.

Faissner S, Ambrosius B, Schanzmann K, Grewe B, Potthoff A, Münch J, Sure U, Gramberg T, Wittmann S, Brockmeyer N, Uberla K, Gold R, Grunwald T, Chan A.

Exp Neurol. 2014 Nov;261:685-97. doi: 10.1016/j.expneurol.2014.08.011. Epub 2014 Aug 19.

PMID:
25150097
27.

Targeting and activation of antigen-specific B-cells by calcium phosphate nanoparticles loaded with protein antigen.

Temchura VV, Kozlova D, Sokolova V, Uberla K, Epple M.

Biomaterials. 2014 Jul;35(23):6098-105. doi: 10.1016/j.biomaterials.2014.04.010. Epub 2014 Apr 26.

PMID:
24776487
28.

Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primates.

Grunwald T, Tenbusch M, Schulte R, Raue K, Wolf H, Hannaman D, de Swart RL, Uberla K, Stahl-Hennig C.

J Virol. 2014 Apr;88(8):3997-4007. doi: 10.1128/JVI.02736-13. Epub 2014 Jan 22.

29.

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells.

Werner B, Dittmann S, Funke C, Überla K, Piper C, Niehaus K, Horstkotte D, Farr M.

Inflamm Res. 2014 Apr;63(4):267-76. doi: 10.1007/s00011-013-0695-z. Epub 2013 Dec 8.

PMID:
24316867
30.

GagPol-specific CD4⁺ T-cells increase the antibody response to Env by intrastructural help.

Nabi G, Genannt Bonsmann MS, Tenbusch M, Gardt O, Barouch DH, Temchura V, Uberla K.

Retrovirology. 2013 Oct 24;10:117. doi: 10.1186/1742-4690-10-117.

31.

HIV-derived lentiviral particles promote T-cell independent activation and differentiation of naïve cognate conventional B2-cells in vitro.

Gardt O, Grewe B, Tippler BG, Überla K, Temchura VV.

Vaccine. 2013 Oct 17;31(44):5088-98. doi: 10.1016/j.vaccine.2013.08.055. Epub 2013 Sep 10.

PMID:
24029115
32.

Protective efficacy and immunogenicity of a combinatory DNA vaccine against Influenza A Virus and the Respiratory Syncytial Virus.

Stab V, Nitsche S, Niezold T, Storcksdieck Genannt Bonsmann M, Wiechers A, Tippler B, Hannaman D, Ehrhardt C, Uberla K, Grunwald T, Tenbusch M.

PLoS One. 2013 Aug 14;8(8):e72217. doi: 10.1371/journal.pone.0072217. eCollection 2013.

33.

Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response.

Tenbusch M, Nchinda G, Storcksdieck genannt Bonsmann M, Temchura V, Überla K.

Int Immunol. 2013 Apr;25(4):247-58. doi: 10.1093/intimm/dxs112. Epub 2012 Nov 26.

PMID:
23184617
34.

The HIV-1 Rev protein enhances encapsidation of unspliced and spliced, RRE-containing lentiviral vector RNA.

Grewe B, Ehrhardt K, Hoffmann B, Blissenbach M, Brandt S, Uberla K.

PLoS One. 2012;7(11):e48688. doi: 10.1371/journal.pone.0048688. Epub 2012 Nov 1.

35.

Selection of a T7 promoter mutant with enhanced in vitro activity by a novel multi-copy bead display approach for in vitro evolution.

Paul S, Stang A, Lennartz K, Tenbusch M, Überla K.

Nucleic Acids Res. 2013 Jan 7;41(1):e29. doi: 10.1093/nar/gks940. Epub 2012 Oct 15.

36.

Risk of immunodeficiency virus infection may increase with vaccine-induced immune response.

Tenbusch M, Ignatius R, Temchura V, Nabi G, Tippler B, Stewart-Jones G, Salazar AM, Sauermann Ü, Stahl-Hennig C, Uberla K.

J Virol. 2012 Oct;86(19):10533-9. doi: 10.1128/JVI.00796-12. Epub 2012 Jul 18.

37.

Immunogenicity of DNA vaccines encoding simian immunodeficiency virus antigen targeted to dendritic cells in rhesus macaques.

Tenbusch M, Ignatius R, Nchinda G, Trumpfheller C, Salazar AM, Töpfer K, Sauermann U, Wagner R, Hannaman D, Tenner-Racz K, Racz P, Stahl-Hennig C, Uberla K.

PLoS One. 2012;7(6):e39038. doi: 10.1371/journal.pone.0039038. Epub 2012 Jun 12.

38.

Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus.

Kamdem Toukam D, Tenbusch M, Stang A, Temchura V, Storcksdieck Genannt Bonsmann M, Grewe B, Koch S, Meyerhans A, Nchinda G, Kaptue L, Uberla K.

PLoS One. 2012;7(5):e38068. doi: 10.1371/journal.pone.0038068. Epub 2012 May 30.

39.

T cell independent secondary antibody responses to the envelope protein of simian immunodeficiency virus.

Nabi G, Temchura V, Grossmann C, Kuate S, Tenbusch M, Überla K.

Retrovirology. 2012 May 14;9:42. doi: 10.1186/1742-4690-9-42.

40.

Cytoplasmic utilization of human immunodeficiency virus type 1 genomic RNA is not dependent on a nuclear interaction with gag.

Grewe B, Hoffmann B, Ohs I, Blissenbach M, Brandt S, Tippler B, Grunwald T, Uberla K.

J Virol. 2012 Mar;86(6):2990-3002. doi: 10.1128/JVI.06874-11. Epub 2012 Jan 18.

41.

Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.

Lietz R, Bayer W, Ontikatze T, Johrden L, Tenbusch M, Storcksdieck Genannt Bonsmann M, Uberla K, Dittmer U, Wildner O.

J Virol. 2012 Feb;86(3):1706-16. doi: 10.1128/JVI.06244-11. Epub 2011 Nov 16.

42.

CCL28 induces mucosal homing of HIV-1-specific IgA-secreting plasma cells in mice immunized with HIV-1 virus-like particles.

Rainone V, Dubois G, Temchura V, Überla K, Clivio A, Nebuloni M, Lauri E, Trabattoni D, Veas F, Clerici M.

PLoS One. 2011;6(10):e26979. doi: 10.1371/journal.pone.0026979. Epub 2011 Oct 31.

43.

Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.

Bayer W, Lietz R, Ontikatze T, Johrden L, Tenbusch M, Nabi G, Schimmer S, Groitl P, Wolf H, Berry CM, Uberla K, Dittmer U, Wildner O.

Retrovirology. 2011 Sep 26;8:75. doi: 10.1186/1742-4690-8-75.

44.

Methods to detect infectious human enteric viruses in environmental water samples.

Hamza IA, Jurzik L, Überla K, Wilhelm M.

Int J Hyg Environ Health. 2011 Nov;214(6):424-36. doi: 10.1016/j.ijheh.2011.07.014. Epub 2011 Sep 15. Review.

PMID:
21920815
45.

Evaluation of pepper mild mottle virus, human picobirnavirus and Torque teno virus as indicators of fecal contamination in river water.

Hamza IA, Jurzik L, Uberla K, Wilhelm M.

Water Res. 2011 Jan;45(3):1358-68. doi: 10.1016/j.watres.2010.10.021. Epub 2010 Oct 23.

PMID:
21074236
46.

Chemical and microbiological parameters as possible indicators for human enteric viruses in surface water.

Jurzik L, Hamza IA, Puchert W, Uberla K, Wilhelm M.

Int J Hyg Environ Health. 2010 Jun;213(3):210-6.

PMID:
20556879
47.

The human immunodeficiency virus type 1 Rev protein: ménage à trois during the early phase of the lentiviral replication cycle.

Grewe B, Uberla K.

J Gen Virol. 2010 Aug;91(Pt 8):1893-7. doi: 10.1099/vir.0.022509-0. Epub 2010 Jun 9. Review.

PMID:
20538907
48.

Nuclear RNA export and packaging functions of HIV-1 Rev revisited.

Blissenbach M, Grewe B, Hoffmann B, Brandt S, Uberla K.

J Virol. 2010 Jul;84(13):6598-604. doi: 10.1128/JVI.02264-09. Epub 2010 Apr 28.

49.

Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells.

Funke C, Farr M, Werner B, Dittmann S, Uberla K, Piper C, Niehaus K, Horstkotte D.

J Gen Virol. 2010 Aug;91(Pt 8):1959-70. doi: 10.1099/vir.0.020065-0. Epub 2010 Apr 14.

PMID:
20392896
50.

Burden of disease due to human coronavirus NL63 infections and periodicity of infection.

van der Hoek L, Ihorst G, Sure K, Vabret A, Dijkman R, de Vries M, Forster J, Berkhout B, Uberla K.

J Clin Virol. 2010 Jun;48(2):104-8. doi: 10.1016/j.jcv.2010.02.023. Epub 2010 Mar 29.

PMID:
20347384

Supplemental Content

Loading ...
Support Center